Porcine Reproductive & Respiratory Syndrome roadmap:
Vaccines
Roadmap for development of a candidate vaccine for PRRSV
Download PRRSV Vaccine Roadmap4
Inactivated vaccines
Development of cross protective/multivalent killed vaccine
Research Question
- The development of an effective killed virus vaccine that gives broad cross-protection but doesn’t contribute to virus evolution
Research Gaps and Challenges
- Having it multivalent
- Having the protective response involving both VN Abs and CTC
- Initial Ab response following natural infection isn’t protective
Solution Routes
- Generation of a range of recombinant viruses expressing protective Antigens from a range of viruses but lacking the dominant Antigen to which the initial non protective Ab response is generated
- Monitoring the immune response following immunisation with the various candidates
- Challenge experiments with the various vaccine candidates. If a multivalent vaccine isn’t possible then a system for rapid development of autologous vaccines will be needed
Dependencies
- Identifying a combination of antigens for expression by a GM strain of the virus or a common single protective Ag to which immune responses are normally suppressed
- The availability of suitable adjuvants to stimulate strong CTC and VN-Ab responses
Projects
What activities are planned or underway?
Generating antibodies broadly neutralising porcine reproductive and respiratory syndrome virus (PRRSV)
Planned Completion date 31/12/2025
Source Countries:
Denmark
Identification of interferon stimulated genes that control Toxoplasma in pig macrophages
Planned Completion date 01/03/2026
Source Countries:
United Kingdom